USP8 and ovarian carcinoma: We assessed the levels and activity of the USP8 protein in different ovarian cancer cell lines including three cisplatin-resistant variants (IGROV-1/Pt1, A2780/CP and A2780/BBR), established by chronic exposure to platinum drugs, using western blot analysis.